Question 1

What are the potential side effects of the CAR-T cell treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma clinical trial (NCT06961669). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma clinical trial (NCT06961669). Contact the study team or your healthcare provider for specific answers.

Question 3

What does the treatment process look like, including any necessary hospital visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma clinical trial (NCT06961669). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma clinical trial (NCT06961669). Contact the study team or your healthcare provider for specific answers.

Question 5

What are the eligibility requirements I need to meet?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma clinical trial (NCT06961669). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or complications during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma clinical trial (NCT06961669). Contact the study team or your healthcare provider for specific answers.

What this study is about